PRODUCT
首頁
產品資訊
PRODUCT
首頁
產品資訊
產品特點
| 編號 | 名稱 | 描述 | 純度 |
| HB4120 | Verruculogen | Selective KCa1. 1 channel blocker | >98% |
| HB0868 | Vigabatrin | Selective, irreversible GABA-T (transaminase) inhibitor | >98% |
| HB4121 | Viridiol | PI3K inhibitor | >95% |
| HB4123 | Vitexin | α-Glucosidase inhibitor | >98% |
| HB0637 | VU 0360223 | mGlu5 negative allosteric modulator | >99% |
| HB1308 | VX 702 | Potent, selective ATP-competitive p38 MAPK inhibitor | >98% |
| HB1309 | VX 745 | Potent, selective p38α MAPK inhibitor | >98% |
| HB0649 | W-5 hydrochloride | Calmodulin (CaM) antagonist | |
| HB4124 | Wedelolactone | Selective IKKα and IKKβ kinase activity inhibitor. NF-κB inhibitor. | >98% |
| HB1431 | WHI-P 154 | Non-selective JAK3 inhibitor and potent EGFR inhibitor. Induces neural progenitor cell differentiation. | >99% |
| HB0657 | WIKI4 | Potent tankyrase inhibitor. Wnt signaling inhibitor. | >98% |
| HB0658 | Wiskostatin | Potent, selective N-WASP inhibitor | >99% |
| HB3155 | Wnt-C59 | Highly potent PORCN inhibitor. Induces iPSC cardiomyocytes differentiation. | >99% |
| HB4126 | Wogonin | Cell permeable COX-2 inhibitor. Increase NO production. | >98% |
| HB2778 | Wortmannin | Potent, selective, irreversible PI3-K inhibitor | |
| HB1781 | WY 45233 succinate | Serotonin/norepinephrine reuptake inhibitor (SNRI) | >99% |
| HB4127 | Xanthorrhizol | Potent COX-2 and iNOS inhibitor | >97% |
| HB1599 | XAP044 | Novel, selective mGlu7antagonist | >98% |
| HB0660 | XAV 939 | Potent tankyrase inhibitor. Wnt/β-catenin signaling inhibitor. | >98% |
| HB1090 | XE 991 dihydrochloride | Potent, selective Kv7 channel blocker | >99% |
| HB1241 | (-)-Xestospongin C | Potent IP3 receptor inhibitor | |
| HB2297 | ROCK inhibitor Y-27632 | Y-27632 is a selective ROCK inhibitor | >98% |
| HB0664 | YM 298198 hydrochloride | Potent, selective, non-competitive mGlu1antagonist | >99% |
| HB1694 | Zacopride hydrochloride | Potent 5-HT3 antagonist and 5-HT4 agonist. Also selective IK1 channel agonist. | >99% |
| HB1152 | ZD 7288 | HCN channel blocker. Modulates sino-atrial node function. | >98% |
| HB1282 | Z-DEVD-FMK | Irreversible, selective caspase 3 inhibitor | |
| HB1283 | Z-DQMD-FMK | Cell permeable caspase 3 specific inhibitor | |
| HB1378 | Zebularine | DNA methyltransferase inhibitor. Induces cardiomyocyte differentiation in MSCs. | >99% |
| HB1753 | Ziprasidone hydrochloride | 5-HT2A and D2 antagonist. Atypical antipsychotic. | >99% |
| HB4134 | Z-Leu-Leu-Leu-B(OH)2 | Highly potent, selective, cell permeable proteasome inhibitor. More potent than MG-132. | >95% |
| HB4136 | Z-Leu-Leu-Nva-CHO | Potent, reversible and cell permeable proteasome inhibitor | >95% |
| HB4137 | Z-Leu-Leu-Phe-CHO | Reversible and cell permeable proteasome inhibitor | >95% |
| HB1444 | ZM 447439 | Potent, selective, ATP-competitive Aurora kinase B inhibitor | >99% |
| HB1137 | Zoniporide dihydrochloride | Potent, selective Na+ / H+exchanger-1 inhibitor | >99% |
| HB0675 | Zonisamide | Non-selective Na+ / Ca2+channel blocker | >99% |
| HB1778 | Zotepine | 5-HT2A and dopamine D2 receptor antagonist. Atypical antipsychotic. | >99% |
| HB1285 | Z-VAD-FMK | Broad spectrum caspase inhibitor | |
| HB1319 | Z-VAD-(OMe)-FMK | Irreversible, cell permeable, broad spectrum caspase inhibitor. | >95% |
| HB1286 | Z-VDVAD-FMK | Irreversible caspase 2 inhibitor | |
| HB4138 | Z-VRPR-FMK | Selective, cell permeable and irreversible MALT1 inhibitor | >90% |